Furthermore, even in a short-term evaluation, ARNI appears to ameliorate LV size and hypertrophy more than angiotensin-converting enzyme inhibitors/angiotensin receptor inhibitors, as concluded in a recent meta-analysis on patients with HF and reduced ejection fraction [68]. Here, ACE is linked to hydrops fetalis.